Spruce Biosciences, Inc.
SPRB
$52.64
$2.875.77%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -90.18% | -86.43% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -90.18% | -86.43% |
| Cost of Revenue | -40.25% | -77.93% | -70.65% | 2.26% | -10.66% |
| Gross Profit | 38.16% | 76.47% | 67.18% | -24.92% | -11.04% |
| SG&A Expenses | 25.30% | 12.64% | 2.37% | -6.81% | -3.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.16% | -57.14% | -53.14% | -0.31% | -8.93% |
| Operating Income | 21.19% | 54.99% | 49.04% | -14.44% | -6.69% |
| Income Before Tax | -6.24% | 32.93% | 26.53% | -21.44% | -12.13% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.24% | 32.93% | 26.53% | -21.44% | -12.13% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.24% | 32.93% | 26.53% | -21.44% | -12.13% |
| EBIT | 21.19% | 54.99% | 49.04% | -14.44% | -6.69% |
| EBITDA | 22.90% | 55.43% | 49.04% | -14.53% | -6.75% |
| EPS Basic | 51.64% | 61.31% | 44.62% | -17.55% | -8.58% |
| Normalized Basic EPS | 58.74% | 67.46% | 50.94% | -17.55% | -8.58% |
| EPS Diluted | 51.64% | 61.31% | 44.62% | -17.55% | -8.58% |
| Normalized Diluted EPS | 58.74% | 67.46% | 50.94% | -17.55% | -8.58% |
| Average Basic Shares Outstanding | 148.32% | 70.82% | 38.06% | 4.67% | 4.47% |
| Average Diluted Shares Outstanding | 148.32% | 70.82% | 38.06% | 4.67% | 4.47% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |